Results 71 to 80 of about 622,177 (374)

Evaluation of Functional Condition of Respiratory Muscles of Patients with a Complicated Bronchial Asthma Pathology and Chronic Obstructive Pulmonary Diseases [PDF]

open access: yes, 2017
The aim of the research was to study the functional state of respiratory muscles and neuro-respiratory drive in patients with a combined pathology of bronchial asthma and chronic obstructive pulmonary disease.The functional condition of the respiratory ...
Feschenko, Y. (Yuriy)   +1 more
core   +2 more sources

Respiratory medicine: anti-IgE therapy, lung cancer and pulmonary hypertension

open access: yesMedicine, 2006
Advances in the treatment of respiratory conditions include the use of anti-immunoglobulin E (IgE) therapy in asthma and endothelin antagonists/phosphodiesterase inhibitors in pulmonary hypertension. In the field of lung cancer, endobronchial ultrasound guided lymph node biopsy can aid in diagnosis and staging, and biological therapies are being used ...
Martin F Muers, Siobhan Mulrennan
openaire   +2 more sources

Interstitial lung disease : raising the index of suspicion in primary care [PDF]

open access: yes, 2014
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in ...
D Zibrak, Joseph, Price, David
core   +2 more sources

Multidrug-resistant tuberculosis in middle ear: A case report

open access: yesJournal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2023
Background: Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB.
Tanze Cao   +5 more
doaj  

Artificial intelligence in pulmonary medicine: computer vision, predictive model and COVID-19

open access: yesEuropean Respiratory Review, 2020
Artificial intelligence (AI) is transforming healthcare delivery. The digital revolution in medicine and healthcare information is prompting a staggering growth of data intertwined with elements from many digital sources such as genomics, medical imaging
D. Khemasuwan   +2 more
semanticscholar   +1 more source

Four patients with a history of acute exacerbations of COPD: implementing the CHEST/Canadian Thoracic Society guidelines for preventing exacerbations [PDF]

open access: yes, 2015
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if ...
A Singanayagam   +43 more
core   +1 more source

Diagnostic performance of a doppler radar-based sleep apnoea testing device

open access: yesBMC Pulmonary Medicine
Background Inpatient polysomnography (PSG) is the gold standard for the diagnosis of obstructive sleep apnoea (OSA), however, both complexity and costs limit the availability of this examination.
Jonathan Röcken   +8 more
doaj   +1 more source

Phenotypes and personalized medicine in the acute respiratory distress syndrome

open access: yesIntensive Care Medicine, 2020
Although the acute respiratory distress syndrome (ARDS) is well defined by the development of acute hypoxemia, bilateral infiltrates and non-cardiogenic pulmonary edema, ARDS is heterogeneous in terms of clinical risk factors, physiology of lung injury ...
M. Matthay   +11 more
semanticscholar   +1 more source

Efficacy of the combination of modern medicine and traditional Chinese medicine in pulmonary fibrosis arising as a sequelae in convalescent COVID-19 patients: a randomized multicenter trial

open access: yesInfectious Diseases of Poverty, 2021
Background The coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has led to a significant number of mortalities worldwide. COVID-19 poses a serious threat to human life. The clinical manifestations
Zhen-hui Lu   +9 more
semanticscholar   +1 more source

MET and NF2 alterations confer primary and early resistance to first‐line alectinib treatment in ALK‐positive non‐small‐cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Alectinib resistance in ALK+ NSCLC depends on treatment sequence and EML4‐ALK variants. Variant 1 exhibited off‐target resistance after first‐line treatment, while variant 3 and later lines favored on‐target mutations. Early resistance involved off‐target alterations, like MET and NF2, while on‐target mutations emerged with prolonged therapy.
Jie Hu   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy